Institutional Ownership
Coherus Oncology Inc
CUSIP 19249H103COMCHRSQ1 2026
13D / 13G Filings
44
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
18.1%
Max % of class reported
Institutional Holders
152
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
44 filings · latest Feb 5, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 5, 2026 | Timothy G. Youngquist 2020 Irrevocable Trust | 13G | 6.5% | 7.85M | SEC |
| 2 | Jan 30, 2026 | The Vanguard Group | 13G/A | 8.3% | 10.03M | SEC |
| 3 | Nov 4, 2025 | Bering Partners II, L.P. ("Bering II") | 13G | 11.0% | 7.60M | SEC |
| 4 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 6.6% | 7.62M | SEC |
| 5 | Apr 16, 2025 | Thomas A. Satterfield, Jr. | 13G | 11.0% | 6.01M | SEC |
| 6 | Feb 13, 2025 | Rubric Capital Management LP | 13G/A | 4.6% | 5.26M | SEC |
| 7 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 9.6% | 11.08M | SEC |
| 8 | Nov 13, 2024 | Rubric Capital Management LP | 13G | 9.0% | 10.40M | SEC |
| 9 | Jul 23, 2024 | Temasek Holdings (Private) Ltd | 13G/A | 4.8% | 5.54M | SEC |
| 10 | May 22, 2024 | Temasek Holdings (Private) Ltd | 13G/A | 5.4% | 6.22M | SEC |
34 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Coherus Oncology Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 10.37M | $17.52M |
| 2 | Samsara Biocapital, LLC | 3.43M | $5.79M |
| 3 | Geode Capital Management, LLC | 3.12M | $5.28M |
| 4 | Kohlberg Kravis Roberts & Co. L.P. | 3.04M | $5.07M |
| 5 | State Street Corp | 2.33M | $3.93M |
| 6 | Two Sigma Investments, LP | 2.30M | $3.89M |
| 7 | Alyeska Investment Group, L.P. | 2.25M | $3.80M |
| 8 | Cm Management, LLC | 2.10M | $3.55M |
| 9 | Tang Capital Management LLC | 1.89M | $3.19M |
| 10 | Hudson Bay Capital Management LP | 1.70M | $2.88M |